Beclometasone/formoterol/glycopyrronium
Beclometasone/formoterol/glycopyrronium, sold under brand name Trimbow, is an inhalable combination drug for the treatment of chronic obstructive pulmonary disease (COPD). It was approved for use in the European Union in July 2017.[2]
| Combination of | |
|---|---|
| Beclometasone dipropionate | Glucocorticoid |
| Formoterol | Long-acting β2 agonist |
| Glycopyrronium bromide | Antimuscarinic |
| Clinical data | |
| Trade names | Trimbow |
| AHFS/Drugs.com | UK Drug Information |
| Routes of administration | Inhalation |
| ATC code | |
| Legal status | |
| Legal status | |
References
- "Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution - Summary of Product Characteristics (SmPC)". (emc). 8 February 2019. Retrieved 5 March 2020.
- "Trimbow EPAR". European Medicines Agency (EMA). 5 March 2020. Retrieved 5 March 2020.
External links
- "Beclometasone dipropionate". Drug Information Portal. U.S. National Library of Medicine.
- "Formoterol". Drug Information Portal. U.S. National Library of Medicine.
- "Glycopyrronium bromide". Drug Information Portal. U.S. National Library of Medicine.
| Adrenergics, inhalants |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Glucocorticoids |
| ||||||||
| Anticholinergics/ muscarinic antagonist | |||||||||
| Mast cell stabilizers | |||||||||
| Xanthines | |||||||||
| Eicosanoid inhibition |
| ||||||||
| Others/unknown | |||||||||
| Combination products |
| ||||||||
| |||||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.